Mark Warner is having a week. On the legislative side, he's rolling out what could be one of the more consequential AI bills of the session: a proposal to create a registry for AI agents and impose a fiduciary duty of loyalty on them, the kind of thing that would touch every major tech platform in the country. On the portfolio side, per his disclosure filings, he bought Microsoft on April 13. Microsoft builds AI agents. The bill is about AI agents. Warner sits on the Senate Intelligence Committee. The public record is allowed to notice.
The Bill
Warner's AI Agent bill, first reported by The Information, would require AI agents to be registered and would hold them to a legal duty of loyalty to the user, not the platform deploying them. The framing is consumer-protection. The practical effect, if it passes, would ripple through every company currently racing to deploy autonomous AI systems: Microsoft, Alphabet, Salesforce, Accenture, and most of the enterprise software stack.
The proposal would also establish fiduciary rules that could constrain how companies monetize AI agents running on behalf of consumers. That's a regulatory surface area worth billions. And Warner, to his credit, is one of the few members of the Senate who would know what he's talking about on this topic. Former tech venture capitalist. Intel Committee member. Has been on the AI beat longer than most of his colleagues have been aware AI is a thing.
The bill has a shot. Or at least more of a shot than most AI legislation, which tends to die in the cloakroom while members argue about whether robots count as people.
The Portfolio
Here's what Blind Trust's disclosure record for Warner shows for April 13, 2026, the same approximate window when this bill was being developed:
- Microsoft (MSFT): Purchase, $1K-$15K
- Accenture (ACN): Purchase, $1K-$15K
- Atlassian (TEAM): Purchase, $1K-$15K
- Constellation Energy (CEG): Purchase, $1K-$15K
- Rocket Companies (RKT): Purchase, $1K-$15K
- Toast (TOST): Purchase, $1K-$15K
- Blackstone (BX): Purchase, $1K-$15K
- Wells Fargo (WFC): Purchase, $1K-$15K
On the sell side that same day: iShares Russell 1000 Growth ETF (IWF), iShares Russell 1000 Value ETF (IWD), and Vanguard Growth ETF (VUG). He rotated out of broad index exposure and into individual names. On a single trading day.
Fifteen disclosed trades total in the last 90 days. That's someone with a view.
The Microsoft Question
Microsoft is the most direct overlap. The company's Copilot product line is one of the highest-profile commercial AI agent deployments in the world. Warner's bill would regulate exactly that category of product. He sits on the Intelligence Committee, which has oversight over AI in national security contexts. He also sits on the Banking Committee's Securities, Insurance, and Investment subcommittee, which has jurisdiction over disclosure and fiduciary obligations in financial products. The bill he's proposing borrows fiduciary-duty language that his own committee has jurisdiction over in other contexts.
Per the alpha record in Warner's disclosure history: the Microsoft purchase on April 13 returned 6.3% alpha over the following 30 days relative to the S&P 500. That's one data point. It doesn't mean anything by itself. It's there.
Accenture is another name worth noting. ACN is one of the largest enterprise AI services firms in the world, the kind of company that would both face regulatory costs from a fiduciary-duty AI bill and potentially benefit from the compliance consulting work it would generate. Warner bought it the same day he bought Microsoft.
The Broader Alpha Record: Not What You'd Expect
If you're expecting a congressman-as-oracle narrative here, the data doesn't cooperate. Over 30 scored trades, Warner is 13 positive, 17 negative, with a mean 30-day alpha of negative 1.5%. He is, by this measure, a below-average stock picker. The market has beaten him more than half the time.
The single best trade in the sample: Atlassian (TEAM), purchased April 13, up 47.3% alpha over the following 30 days. That's a genuine outlier. TEAM makes enterprise collaboration software increasingly integrated with AI workflows. No committee overlap flagged on that one. A good trade is a good trade.
The worst: Cheniere Energy-adjacent LNG, sold March 20, negative 20.1% alpha. He sold it and it ran. Wells Fargo, bought April 13, is sitting at negative 8.7% alpha. Warner is on the Banking Committee's subcommittee on Financial Institutions and Consumer Protection. WFC is a bank. That's a committee-overlap trade that has not gone well.
The Amgen Situation
The two worst committee-overlap trades in the recent record are the Amgen sales. Warner sold Amgen on April 6 and again on April 7, both in the $1K-$15K range. The 30-day alpha on those sales came in at negative 14.4% and negative 12.9%, respectively. He sold. The stock went up relative to the market.
Warner is not on the HELP Committee. He is on Finance, which has a Health Care subcommittee. Amgen is a large-cap biotech. The committee overlap designation in the data flags this as a Biotechnology overlap. The sales were not prescient. They cost him alpha.
The record across all five committee-overlap trades: one winner in banks (Fifth Third Bancorp, up 7.8% alpha), one winner in tech (Microsoft, up 6.3%), one small winner in tech (Apple, up 2.8%), one loser in banks (Wells Fargo, down 8.7%), and the Amgen sales. Three slightly positive, two negative. That's the conflict-of-interest angle in Warner's portfolio: it exists, and it hasn't made him rich.
The Election Angle
Warner is not just a senator writing AI bills. He's a senator up for reelection this fall in Virginia, where three Republicans are currently competing to take him on. It's positioning. Warner built his pre-Senate career in telecommunications and venture capital. The AI beat is his home turf, and he knows it reads well in a state with a massive federal contractor and tech-sector presence in Northern Virginia.
The bill is also genuinely interesting on the merits, which is what makes the portfolio question more pointed, not less. A senator who doesn't understand the technology doesn't create a tension. A senator who understands it well enough to write coherent legislation about it, and who holds positions in the companies that legislation would govern, is the person the disclosure system was designed to make visible.
What the System Permits
Members are required to disclose. They are not required to divest, recuse, or abstain. A senator can draft legislation affecting an industry, hold stock in that industry, and vote on that legislation, all without violating any rule. The disclosure system's entire premise is that sunlight is sufficient. Warner's filings are current. The trades are disclosed. The bill is public.
The receipts are public. Make of them what you make of them.